Why the study?
Do SGLT2 inhibitors reduce the incidence of atrial fibrillation in patients with type 2 diabetes mellitus?
Do SGLT2 inhibitors reduce the incidence of atrial fibrillation in patients with type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
SGLT2 inhibitors may reduce the risk of developing atrial fibrillation in patients with type 2 diabetes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lüdde et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: